217 related articles for article (PubMed ID: 29371698)
41. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
Cho KH; Yu SL; Cho DY; Park CG; Lee HY
BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
[TBL] [Abstract][Full Text] [Related]
42. STAT3 mediates RCP-induced cancer cell invasion through the NF-κB/Slug/MT1-MMP signaling cascade.
Cho SJ; Jeong BY; Song YS; Park CG; Cho DY; Lee HY
Arch Pharm Res; 2022 Jul; 45(7):460-474. PubMed ID: 35809175
[TBL] [Abstract][Full Text] [Related]
43. Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion.
Onodera Y; Nam JM; Hashimoto A; Norman JC; Shirato H; Hashimoto S; Sabe H
J Cell Biol; 2012 Jun; 197(7):983-96. PubMed ID: 22734003
[TBL] [Abstract][Full Text] [Related]
44. The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
Wu Y; Hooper AT; Zhong Z; Witte L; Bohlen P; Rafii S; Hicklin DJ
Int J Cancer; 2006 Oct; 119(7):1519-29. PubMed ID: 16671089
[TBL] [Abstract][Full Text] [Related]
45. MCP-1-induced ERK/GSK-3β/Snail signaling facilitates the epithelial-mesenchymal transition and promotes the migration of MCF-7 human breast carcinoma cells.
Li S; Lu J; Chen Y; Xiong N; Li L; Zhang J; Yang H; Wu C; Zeng H; Liu Y
Cell Mol Immunol; 2017 Jul; 14(7):621-630. PubMed ID: 26996066
[TBL] [Abstract][Full Text] [Related]
46. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
47. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
48. Increased Rab25 expression is not correlated with peritoneal metastasis of ovarian cancers.
Zhao M; Yin YX; Guo F; Yang YY; Shen F; Chen Q
Cancer Invest; 2012 Nov; 30(9):683-7. PubMed ID: 23030522
[TBL] [Abstract][Full Text] [Related]
49. Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.
Horikawa N; Abiko K; Matsumura N; Hamanishi J; Baba T; Yamaguchi K; Yoshioka Y; Koshiyama M; Konishi I
Clin Cancer Res; 2017 Jan; 23(2):587-599. PubMed ID: 27401249
[TBL] [Abstract][Full Text] [Related]
50. VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug.
Kim M; Jang K; Miller P; Picon-Ruiz M; Yeasky TM; El-Ashry D; Slingerland JM
Oncogene; 2017 Sep; 36(36):5199-5211. PubMed ID: 28504716
[TBL] [Abstract][Full Text] [Related]
51. Kindlin-3 enhances breast cancer progression and metastasis by activating Twist-mediated angiogenesis.
Sossey-Alaoui K; Pluskota E; Davuluri G; Bialkowska K; Das M; Szpak D; Lindner DJ; Downs-Kelly E; Thompson CL; Plow EF
FASEB J; 2014 May; 28(5):2260-71. PubMed ID: 24469992
[TBL] [Abstract][Full Text] [Related]
52. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level.
Kurrey NK; K A; Bapat SA
Gynecol Oncol; 2005 Apr; 97(1):155-65. PubMed ID: 15790452
[TBL] [Abstract][Full Text] [Related]
53. Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer.
Kikuchi M; Yamashita K; Waraya M; Minatani N; Ushiku H; Kojo K; Ema A; Kosaka Y; Katoh H; Sengoku N; Enomoto T; Tanino H; Sawanobori M; Watanabe M
Oncotarget; 2016 Jan; 7(2):1741-53. PubMed ID: 26646320
[TBL] [Abstract][Full Text] [Related]
54. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
[TBL] [Abstract][Full Text] [Related]
55. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
[TBL] [Abstract][Full Text] [Related]
56. Rab25 and RCP in cancer progression.
Cho KH; Lee HY
Arch Pharm Res; 2019 Feb; 42(2):101-112. PubMed ID: 30761451
[TBL] [Abstract][Full Text] [Related]
57. Filamin A upregulation correlates with Snail-induced epithelial to mesenchymal transition (EMT) and cell adhesion but its inhibition increases the migration of colon adenocarcinoma HT29 cells.
Wieczorek K; Wiktorska M; Sacewicz-Hofman I; Boncela J; Lewiński A; Kowalska MA; Niewiarowska J
Exp Cell Res; 2017 Oct; 359(1):163-170. PubMed ID: 28778796
[TBL] [Abstract][Full Text] [Related]
58. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
59. A CRE that binds CREB and contributes to PKA-dependent regulation of the proximal promoter of human RAB25 gene.
Xue H; Qiao Y; Ni P; Wang J; Chen C; Huang G
Int J Biochem Cell Biol; 2011 Mar; 43(3):348-57. PubMed ID: 21075212
[TBL] [Abstract][Full Text] [Related]
60. Loss of RAB25 expression in breast cancer.
Cheng JM; Ding M; Aribi A; Shah P; Rao K
Int J Cancer; 2006 Jun; 118(12):2957-64. PubMed ID: 16395697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
